DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

The list of Fiscal Year 2022 Breast Cancer Research Program Breakthrough Award - Funding Level 3 - Clinical Trial applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.

Institution Principal Investigator
MBQ Pharma, Inc.Jose Rodriguez

Last updated Friday, December 2, 2022